November 5, 2009
Author(s)
Denis E. Bergeron, Brian E. Zimmerman, Jeffrey T. Cessna
223Ra is a bone-seeking alpha emitter, and as such is currently being evaluated as a radiopharmaceutical for the treatment of skeletal metastases. In the clinical setting, dosage measurements are typically achieved with reentrant ionization chambers